Sermorelin

Each Sermorelin 5 mg batch released by Vertex Labs is supported by batch-level documentation and Certificate of Analysis availability following quality review. Documentation may include identity confirmation, purity assessment, active weight verification, labeling review, and other analytical information relevant to the specific research batch.

Review available batch documentation through the
Vertex Labs COA database.
Additional information regarding laboratory review procedures, documentation standards, and quality controls is available on our
Testing Standards page.

Sermorelin 5 mg should be handled using established laboratory practices and appropriate internal quality procedures. Personnel should review the labeled strength, product labeling, batch-specific documentation, container condition, and applicable storage requirements before use in a controlled laboratory environment.

Keep the vial sealed until required for laboratory preparation and store the material according to the conditions specified on the product label. Laboratories should maintain appropriate handling, documentation, and material-control procedures for their research environment.

Sermorelin is identified by its defined 29-amino-acid sequence, YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH₂, associated molecular characteristics, and labeled 5 mg fill amount. These identifiers help distinguish the material from other GHRH-related peptide research compounds and support accurate documentation within controlled laboratory environments.

Researchers should verify the 5 mg strength, vial labeling, batch number, sequence information, and corresponding analytical documentation before use. Maintaining clear material identification and batch traceability supports consistency across laboratory workflows.